← Evidence library

BIB_165

INTerpath-001 / V940-002 (NCT05933577). Phase III mRNA-4157 (V940) + pembro vs pembro in resected Stage IIB-IV melanoma. ~1,089 enrolled; primary endpoint RFS; expected primary completion ~2027. UK sites incl. select centres (Royal Marsden et al.). [Tasks: 17, 18] Tier: 1 (RCT) Grade: A (in progress) Retrieved: 2026-05-07

Evidence grade

A

Tier

1 (RCT)

Cited by tasks

17, 18

Identifiers

—

Full extracted findings & patient-implication analysis: bibliography/BIB_165/findings.md (research corpus). This page is a short context summary — not individualised medical advice.